FOCUSING on IMPROVING THE LIVES of PATIENTS

WITH DIFFICULT-TO-TREAT DISEASES

RECENT NEWS

BioMed Valley Discoveries’ ulixertinib (BVD-523) receives Fast Track designation and launches Phase II trial. See details here.

July 28, 2020

COMBINING the EXPERTISE of our TEAM and our PARTNERS to BREAK THROUGH BARRIERS in EARLY STAGE DRUG DEVELOPMENT